Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Arteriocyte Medical Systems Inc.

Division of ISTO Technologies Inc./Arteriocyte Medical Systems Inc.
www.arteriocyte.com

Latest From Janssen Pharmaceuticals Inc.

J&J's Symtuza Will Debut In Europe On Cramped HIV Market

Johnson & Johnson's combination HIV therapy Symtuza has secured a greenlight in Europe, marking its first approval worldwide – but will the big pharma be able to catch up with successful HIV opponents from AbbVie and Gilead?

Infectious Diseases Approvals

Provenge To Drive Sanpower Growth And Wider China Cell Therapy Market?

China will provide a rising market potential for Sanpower’s newly acquired Dendreon and its Provenge product for prostate cancer, as part of the Chinese firm’s broader strategy, and the deal could also have an impact on the regulatory climate for cellular immunotherapies in China.

China Commercial

AbbVie Hikes Doc Payments By 135%, Merck By 86% As BMS, J&J Cut Spending

Under CMS' Open Payments program, medical product manufacturers reported $8.1bn in payments and ownership and investment interests to physicians and teaching hospitals in 2016, a 1% increase from the previous year.

Advertising, Marketing & Sales Clinical Trials

FDA Conflict Of Interest Waiver On Victoza Is Textbook Example For Supporters, Foes

Novo Nordisk's Victoza will get US advisory committee review June 20, and Tufts Medical Center's Marvin Konstam will serve on panel even though his institution participates in a trial for Janssen's Invokana.

Advisory Committees FDA
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Medical Devices
    • Biomaterials
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Cardiovascular
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • ISTO Technologies Inc.
  • Senior Management
  • Donald Brown, CEO
    John Mitchell, CFO
    Larry Davis, VP, Sales
  • Contact Info
  • Arteriocyte Medical Systems Inc.
    Phone: (866) 660-2674
    45 South St.
    Hopkinton, MA 01748
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register